Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hammill, Joanne A.
28  Ergebnisse:
Personensuche X
?
1

T-cell engineered with a fully humanized B-cell maturation ..:

Bezverbnaya, Ksenia ; Hammill, Joanne A. ; Cummings, Derek...
Cytotherapy.  25 (2023)  5 - p. 490-501 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Metformin-induced reductions in tumor growth involves modul..:

Broadfield, Lindsay A. ; Saigal, Amna ; Szamosi, Jake C....
Molecular Metabolism.  61 (2022)  - p. 101498 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Manufacturing T cells in hollow fiber membrane bioreactors ..:

Yoo, Seung Mi ; Lau, Vivan W.C. ; Aarts, Craig...
OncoImmunology.  10 (2021)  1 - p. , 2021
Link: https://doi.org/10.1080/..
 
?
4

Expanded human NK cells armed with CAR uncouple potent anti..:

Portillo, Ana L. ; Hogg, Richard ; Poznanski, Sophie M....
iScience.  24 (2021)  6 - p. 102619 , 2021
Link: https://doi.org/10.1016/..
 
?
5

A Cross-Reactive Small Protein Binding Domain Provides a Mo..:

Hammill, Joanne A. ; Kwiecien, Jacek M. ; Dvorkin-Gheva, Anna...
Molecular Therapy - Oncolytics.  17 (2020)  - p. 278-292 , 2020
Link: https://doi.org/10.1016/..
 
?
6

The chimeric TAC receptor co-opts the T cell receptor yield..:

Helsen, Christopher W. ; Hammill, Joanne A. ; Lau, Vivian W. C....
Nature Communications.  9 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
7

AMPK β1 reduces tumor progression and improves survival in ..:

Houde, Vanessa P. ; Donzelli, Sara ; Sacconi, Andrea...
Molecular Oncology.  11 (2017)  9 - p. 1143-1155 , 2017
Link: https://doi.org/10.1002/..
 
?
8

Designed ankyrin repeat proteins are effective targeting el..:

Hammill, Joanne A. ; VanSeggelen, Heather ; Helsen, Christopher W....
Journal for ImmunoTherapy of Cancer.  3 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
9

T Cells Engineered With Chimeric Antigen Receptors Targetin..:

VanSeggelen, Heather ; Hammill, Joanne A ; Dvorkin-Gheva, Anna...
Molecular Therapy.  23 (2015)  10 - p. 1600-1610 , 2015
Link: https://doi.org/10.1038/..
 
?
10

Chimeric antigen receptor–engineered T cells as oncolytic v..:

VanSeggelen, Heather ; Tantalo, Daniela GM ; Afsahi, Arya..
Molecular Therapy - Oncolytics.  2 (2015)  - p. 15014 , 2015
Link: https://doi.org/10.1038/..
 
?
11

Combined mTOR Inhibition and OX40 Agonism Enhances CD8+ T C..:

Bassett, Jennifer D ; Swift, Stephanie L ; VanSeggelen, Heather...
Molecular Therapy.  20 (2012)  4 - p. 860-869 , 2012
Link: https://doi.org/10.1038/..
 
?
12

Metformin-induced reductions in tumor growth involves modul..:

Broadfield, Lindsay A ; Saigal, Amna ; Szamosi, Jake C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096669/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Expanded human NK cells armed with CAR uncouple potent anti..:

Portillo, Ana L ; Hogg, Richard ; Poznanski, Sophie M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193615/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

A Cross-Reactive Small Protein Binding Domain Provides a Mo..:

Hammill, Joanne A ; Kwiecien, Jacek M ; Dvorkin-Gheva, Anna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191649/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

The chimeric TAC receptor co-opts the T cell receptor yield..:

Helsen, Christopher W ; Hammill, Joanne A ; Lau, Vivian W. C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076291/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
1-15